RGBP Regen Biopharma, Inc.

Fundamentals / CIK 0001589150 / USD
Other share classes on CIK 0001589150: RGBPP

Regen Biopharma, Inc. reported $237K in revenue and a net loss of $1.19M for the trailing twelve months ended June 30, 2026 (flat year over year), with a -339.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RGBP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$4.18M$2.09M$0-$7.54MFY 2016 Revenue: $100KFY 2016 Net Income: -$7.75M2016FY 2017 Revenue: $110KFY 2017 Net Income: -$5.84M2017FY 2018 Revenue: $100KFY 2018 Net Income: -$4.72M2018FY 2019 Revenue: $110KFY 2019 Net Income: -$2.62M2019FY 2020 Revenue: $110KFY 2020 Net Income: $3.41M2020FY 2021 Revenue: $61KFY 2021 Net Income: -$6.77M2021FY 2022 Revenue: $126KFY 2022 Net Income: $2.44M2022FY 2023 Revenue: $127KFY 2023 Net Income: $1.16M2023FY 2024 Revenue: $237KFY 2024 Net Income: -$668K2024FY 2025 Revenue: $237KFY 2025 Net Income: -$1.27M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue $237K $237K $127K $126K $61K $110K $110K $100K $110K $100K
Research & Development $12K $154K $212K $158K $37K $13K $46K $374K $1.15M $671K
Total Operating Expenses $575K $654K $924K -- -- -- -- -- -- --
Operating Income -$339K -$417K -$687K -$340K -$201K -$209K -$757K -$1.43M -$2.51M -$2.96M
Interest Income -- -- -- -- -- $0 $1.3K -- -- --
Interest Expense $158K $72K $59K $139K $316K $333K $295K $259K $99K $28K
Income Before Tax -$1.27M -$668K $1.16M -- -- -- -- -- -- --
Income Tax Expense $0 $0 -- -- -- -- -- -- -- --
Net Income -$1.27M -$668K $1.16M $2.44M -$6.77M $3.41M -$2.62M -$4.72M -$5.84M -$7.75M
Basic EPS -$0.05 -$0.16 $0.29 $0.71 -$0.00 $0.00 -$0.00 -$0.03 -$0.04 -$0.06
Diluted EPS -$0.05 -$0.16 $0.29 $0.71 -$0.00 $0.00 -$0.00 -$0.03 -$0.04 -$0.06
Basic Shares Outstanding 23.5M 4.1M 3.5M 3.1M 3.01B 1.41B 2.07B 152.1M 141.4M 127.8M
Diluted Shares Outstanding 23.5M 4.1M 3.5M 3.1M -- -- -- -- -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $59K $59K $59K $59K $59K $59K $59K $59K
Research & Development $0 $2.2K $210K $12K $0 $0 $0 $34K
Total Operating Expenses $35K $213K $611K $182K $100K $172K $120K $145K
Operating Income $25K -$154K -$552K -$123K -$41K -$113K -$61K -$85K
Interest Expense $30K $27K $27K $86K $25K $22K $25K $20K
Income Before Tax -$638K $992K -$968K -$572K -$167K -$19K -$515K -$271K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 --
Net Income -$638K $992K -$968K -$572K -$167K -$19K -$515K -$271K
Basic EPS $0.00 $0.00 -$0.01 -- -$0.01 $0.00 -$0.13 --
Diluted EPS $0.00 $0.00 -$0.01 -- -$0.01 $0.00 -$0.13 --
Basic Shares Outstanding 615.6M 184.9M 99.6M -- 23.8M 21.6M 4.1M --
Diluted Shares Outstanding 615.6M 184.9M 99.6M -- 23.8M 21.6M 4.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $70K $716 $121K $51K $727K $0 $7.9K $8.0K $270K $25K
Cash & Short-Term Investments $70K $716 $121K $51K $727K $0 $7.9K $8.0K $270K $25K
Accounts Receivable, Net $205K $95K $0 $254K $213K $103K $71K $0 $0 $83K
Total Current Assets $275K $143K $131K $336K $994K $103K $79K $43K $478K $207K
Long-Term Investments -- $18K -- -- -- -- -- -- -- --
Total Non-Current Assets $0 $18K $223K $223K $218K $20K $20K $166K $466K $112K
Total Assets $275K $161K $354K $559K $1.21M $123K $99K $209K $944K $319K
Accounts Payable $1.7K $30K $30K $29K $91K $110K $92K $81K $496K $241K
Short-Term Debt -- -- -- -- -- -- -- -- -- $107K
Deferred Revenue (Current) $1.34M $1.47M -- -- -- -- -- -- -- --
Other Current Liabilities $100K $21K $21K -- -- -- -- -- -- --
Total Current Liabilities $6.56M $5.38M $5.31M $8.60M $14.70M $7.46M $11.00M $8.67M $5.86M $799K
Total Non-Current Liabilities $0 $0 $150K $0 $0 $0 $5.0K $657K $332K $107K
Total Liabilities $6.56M $5.38M $5.46M $8.60M $14.70M $7.46M $11.01M $9.33M $6.20M $906K
Total Debt (incl. Leases) -- -- -- -- -- -- -- -- -- $107K
Common Stock $3.9K $527 $352 $503K $435K $160K $60K $18K $14K $14K
Retained Earnings -$21.69M -$20.42M -$19.75M -$20.91M -$23.35M -$16.58M -$20.00M -$17.46M -$12.74M -$20.22M
Accumulated Other Comp. Income -$223K -$205K -- -- -- -- $0 $53K $88K -$80K
Total Stockholders' Equity -$6.28M -$5.22M -$5.10M -$8.04M -$13.49M -$7.33M -$10.91M -$9.12M -$5.25M -$587K
Total Equity -$6.28M -$5.22M -$5.10M -$8.04M -$13.49M -$7.33M -$10.91M -$9.12M -$5.25M -$587K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $239 $271 $4.6K $70K $1.8K $1.8K $135 $716
Cash & Short-Term Investments $239 $271 $4.6K $70K $1.8K $1.8K $135 $716
Accounts Receivable, Net $287K $260K $232K $205K $177K $150K $122K $95K
Total Current Assets $288K $260K $237K $275K $179K $152K $174K $143K
Long-Term Investments -- -- -- -- $18K -- -- $18K
Total Non-Current Assets $0 $0 $0 $0 $18K $18K $18K $18K
Total Assets $288K $260K $237K $275K $197K $169K $191K $161K
Accounts Payable $21K $20K $11K $1.7K $30K $34K $36K $30K
Deferred Revenue (Current) $1.24M $1.28M $1.31M $1.34M $1.37M -- -- $1.47M
Other Current Liabilities $100K $100K $100K $100K $21K $21K $21K $21K
Total Current Liabilities $6.17M $5.62M $6.81M $6.56M $6.01M $5.87M $5.87M $5.38M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $6.17M $5.62M $6.81M $6.56M $6.01M $5.87M $5.87M $5.38M
Common Stock $113K $35K $11K $3.9K $3.2K $2.2K $2.2K $527
Retained Earnings -$22.31M -$21.67M -$22.66M -$21.69M -$21.12M -$20.95M -$20.93M -$20.42M
Accumulated Other Comp. Income -$223K -$223K -$223K -$223K -$205K -$205K -$205K -$205K
Total Stockholders' Equity -$5.88M -$5.36M -$6.57M -$6.28M -$5.82M -$5.70M -$5.68M -$5.22M
Total Equity -$5.88M -$5.36M -$6.57M -$6.28M -$5.82M -$5.70M -$5.68M -$5.22M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$1.27M -$668K $1.16M $2.44M -$6.77M $3.41M -$2.62M -$4.72M -$5.84M -$7.75M
Stock-Based Compensation -- $13K $348K -- -- -- -- -- -- --
Change in Receivables -$110K -$95K $254K -$41K -$110K -$34K -$71K $0 -$83K $83K
Change in Payables $821 -$7 $876 -$63K -$19K $18K $11K -$415K $255K $215K
Operating Cash Flow -$384K -$752K -$174K -$607K -$1.13M $19K -$482K -$1.58M -$1.89M -$1.67M
Investing Cash Flow -- -- -- $25K $495K $0 $50K -$5.7K $0 --
Common Stock Issued $58K $564K -- -- -- -- -- -- -- --
Financing Cash Flow $452K $631K $244K -$94K $1.36M -$26K $432K $1.32M $2.14M $1.66M
Net Change in Cash $69K -$120K $70K -$676K $727K -$7.9K -$164 -$262K $245K -$14K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$638K $992K -$968K -$572K -$167K -$19K -$515K -$271K
Change in Receivables -$27K -$27K -$27K -$28K -$27K -$27K -$27K -$28K
Change in Payables $468 $9.1K $9.3K $13 -$3.2K -$2.3K $6.3K $251
Operating Cash Flow -$24K -$63K -$198K -$160K -$56K -$101K -$66K -$207K
Common Stock Issued $0 $50K $192K -- -- -- -- $28K
Financing Cash Flow $24K $59K $133K $228K $56K $103K $66K $146K
Net Change in Cash -$32 -$4.3K -$65K $68K -$1 $1.6K -$581 -$61K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Operating Margin -143.1% -176.4% -542.8% -270.6% -328.1% -190.3% -688.0% -1425.8% -2282.6% -2957.0%
Net Profit Margin -538.8% -282.5% 913.8% 1946.8% -11055.4% 3104.0% -2384.7% -4715.2% -5308.2% -7750.6%
Return on Assets (ROA) -464.1% -414.8% 327.1% 437.1% -558.1% 2771.7% -2647.3% -2255.9% -618.4% -2426.9%
Current Ratio 0.04x 0.03x 0.02x 0.04x 0.07x 0.01x 0.01x 0.00x 0.08x 0.26x
Quick Ratio 0.04x 0.02x 0.02x 0.04x 0.06x 0.01x 0.01x 0.00x 0.05x 0.13x
Revenue Growth (YoY) 0.0% +86.9% +0.8% +105.1% -44.4% 0.0% +10.0% -9.1% +10.0% -47.9%
Net Income Growth (YoY) -- -157.8% -52.7% -- -298.1% -- -- -- -- --
EPS Growth (YoY) -- -155.2% -59.2% -- -212.5% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -6165.6% -- -- -- -- --
5Y Revenue / Share Growth +12789.9% +108265.6% +5342.1% +5046.2% -97.4% -96.4% -- -- -- --
10Y Revenue / Share Growth +361.9% -- -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -2337.3% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -339.8% -367.4% -350.3% -143.1% -127.2% -155.6% -170.1% -229.6%
Net Profit Margin -501.4% -302.5% -730.0% -538.8% -411.2% -395.5% -496.7% -367.8%
Return on Assets (ROA) -412.5% -275.1% -728.4% -464.1% -494.2% -552.0% -542.6% -414.8%
Current Ratio 0.05x 0.05x 0.03x 0.04x 0.03x 0.03x 0.03x 0.03x
Quick Ratio 0.05x 0.05x 0.03x 0.04x 0.03x 0.03x 0.02x 0.02x
Revenue Growth (YoY) 0.0% 0.0% 0.0% 0.0% 0.0% +86.7% +86.7% --
Source: SEC EDGAR CompanyFacts (CIK 0001589150) · from December 31, 2012 Data through June 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal